Targeted repair of oral mucosal injury: emerging applications of biomaterials-based drug delivery systems
Yu J., Li X., Fu X., Wen J., Jiang Y., Kuang Q.
Narrative Review on Face & Skin, published in J Nanobiotechnology (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- J Nanobiotechnology (2026)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 41645265
- PMCID
- PMC12964871
- DOI
- 10.1186/s12951-026-04117-7
- Citations
- 1
Abstract (original English)
The oral mucosa, as an important barrier to external exposure, is susceptible to damage caused by various factors, leading to a series of clinical symptoms. Traditional treatment methods have problems such as short drug retention time and unstable local exposure, which make it difficult to meet the treatment needs of oral mucosal injuries. Biomaterials-based drug delivery system can significantly improve the local residence time, permeability and bioavailability of drugs through ultra-small particle size, surface modification and controllable release characteristics, and provide precise targeted therapy. This paper summarizes the application of biomaterials-based drug delivery system in oral mucosal injury, and analyzes its advantages in multi-stage collaborative treatment, including prevention of disease, effective treatment and promotion of rehabilitation. Although the current biomaterials-based system has made some progress in improving treatment effect and patient compliance, it still faces challenges such as long-term safety and manufacturing differences. In the future, biomaterials-based drug delivery system is expected to become an important tool for the treatment of oral mucosal diseases and play an important role in clinical practice.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
Oncologic safety of autologous fat grafting in head and neck cancer patients: A scoping review.
Systematic Review with a reported sample of 116 on Face & Skin, published in Med Oral Patol Oral Cir Bucal (2026) — summary generated from the PubMed abstract.
- 2026
- n = 116
Med Oral Patol Oral Cir Bucal - Level ASystematic ReviewEurope PMC
Stem cell-derived exosomes in tissue regeneration of oral and maxillofacial region: A systematic review
Systematic Review on Chronic Wound, published in Medicine (Baltimore) (2026) — summary generated from the PubMed abstract.
- 2026
Medicine (Baltimore) - Level AMeta-analysisPubMed
Stromal Vascular Fraction-Assisted Fat Grafting: A Systematic Review and Meta-analysis of Clinical Outcomes.
Meta-analysis on Face & Skin, published in Aesthetic Plast Surg (2026) — summary generated from the PubMed abstract.
- 2026
Aesthetic Plast Surg - Level ASystematic ReviewEurope PMC
Applications of Exosomes in Female Medicine: A Systematic Review of Molecular Biology, Diagnostic and Therapeutic Perspectives
Systematic Review on Face & Skin, Systemic / IV, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci2 citations - Level ASystematic ReviewPubMed
The use of cellular therapies for trigeminal neuralgia: a systematic review of behavioral and molecular outcomes.
Systematic Review with a reported sample of 8 on Neuroinflammation, published in Neurosurg Rev (2026) — summary generated from the PubMed abstract.
- 2026
- n = 8
Neurosurg Rev - Level ASystematic ReviewEurope PMC
Osteogenic and Biocompatibility Potential of Polylactic Acid-Based Materials: A Systematic Review of Human Primary Cells Studies
Systematic Review on Face & Skin, published in J Funct Biomater (2026) — summary generated from the PubMed abstract.
- 2026
J Funct Biomater